C-RAD tillkännager en viktig milstolpe inom partikelterapi med en order från marknadsledaren inom protonterapi Ion Beam Applications S.A. (IBA). Ordern består av 10 Catalyst+ PT och 10 Sentinel, som ska…
Read More
C-RAD announces a significant milestone in the field of particle therapy with an order from the proton therapy market leader Ion Beam Applications S.A. (IBA) for 10 Catalyst+ PT and…
Agreement at a value of 16 MSEK signed between C-RAD and customer in North Rhine-Westphalia, Germany
C-RAD is re-confirmed as a partner for outstanding radiotherapy by a clinic in North Rhine-Westphalia, Germany. A C-RAD customer in North Rhine-Westphalia, Germany decides to expand the existing SGRT solution…
C-RAD är utvald som partner för strålbehandling av en klinik i Nordrhein-Westfalen, Tyskland. En befintlig kund till C-RAD i Nordrhein-Westfalen, Tyskland, har beslutat att utöka med ytterligare Catalystsystem för ytskanningsteknik….
One of the most accomplished cancer programs in the U.S., Atrium Health Levine Cancer, is scheduled to open its new Atrium Health Proton & Advanced Radiation Center in late 2023….
Katholisches Klinikum Bochum gGmbH – St. Josef Hospital in Bochum, Germany, has decided to use the C-RAD SGRT solution in its modernised radiotherapy. The order, which has a value, before…
Katholisches Klinikum Bochum gGmbH – St. Josef Hospital i Bochum, Tyskland, har fattat beslut kring att använda C-RAD:s teknologi för ytskanning i samband med strålbehandling. Ordern, som har ett värde,…
During 21 August 2023 and 23 August 2023, C-RAD AB (publ) (LEI code 549300SPXLHF15W2CU25), has repurchased in total 28,500 own B-shares (ISIN: SE0002016352). The repurchase is carried out in accordance…
Mellan den 21 augusti 2023 och den 23 augusti 2023, har C-RAD AB (publ) (LEI code 549300SPXLHF15W2CU25), återköpt sammanlagt 28 500 egna B-aktier (ISIN: SE0002016352). Återköpen genomförs i enlighet med…
During 15 August 2023 and 18 August 2023, C-RAD AB (publ) (LEI code 549300SPXLHF15W2CU25), has repurchased in total 60,000 own B-shares (ISIN: SE0002016352). The repurchase is carried out in accordance…